Damora Therapeutics, Inc. (DMRA)
NCM · Healthcare · Biotechnology
$21.71
+0.84%
Closing price as of 2026-10-22 · Source: TEK2day Finance
Key Metrics
Market Cap
$1.34B
Shares Outstanding
61.7M
Exchange
NCM
Currency
USD
Quarterly Financials
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (3.2M) | (201.7M) | (30.8M) | (35.0M) |
| Net Income | (3.1M) | (200.7M) | (27.8M) | (31.2M) |
| Diluted EPS | $-2.36 | N/A | $-0.62 | $-0.39 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (61.2M) | (36.5M) | (21.3M) | (210.9M) |
| Net Income | (61.6M) | (38.3M) | (21.4M) | (209.8M) |
| Diluted EPS | $-60.75 | $-36.08 | $-18.53 | $-3.98 |